Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsThe authors utilized an intestinal organoid approach to compare in vitro responses to two CFTR modulator drug combinations and to check potential inter-individual variability in therapeutic response to the triple combination.
[Journal of Cystic Fibrosis]
6445212 6PJP9AZ4 items 1 apa 0 default asc 1 165381 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-34a56323893df4d2bd0a87b2641db98c%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%226PJP9AZ4%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Furstova%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFurstova%2C%20E.%2C%20Dousova%2C%20T.%2C%20Beranek%2C%20J.%2C%20Libik%2C%20M.%2C%20Fila%2C%20L.%2C%20Modrak%2C%20M.%2C%20Cinek%2C%20O.%2C%20Macek%2C%20M.%2C%20%26amp%3B%20Drevinek%2C%20P.%20%282021%29.%20Response%20to%20elexacaftor%5C%2Ftezacaftor%5C%2Fivacaftor%20in%20intestinal%20organoids%20derived%20from%20people%20with%20cystic%20fibrosis.%20%3Ci%3EJournal%20of%20Cystic%20Fibrosis%3C%5C%2Fi%3E%2C%20%3Ci%3E0%3C%5C%2Fi%3E%280%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcf.2021.07.006%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcf.2021.07.006%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3D6PJP9AZ4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Response%20to%20elexacaftor%5C%2Ftezacaftor%5C%2Fivacaftor%20in%20intestinal%20organoids%20derived%20from%20people%20with%20cystic%20fibrosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eva%22%2C%22lastName%22%3A%22Furstova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tereza%22%2C%22lastName%22%3A%22Dousova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakub%22%2C%22lastName%22%3A%22Beranek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malgorzata%22%2C%22lastName%22%3A%22Libik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Libor%22%2C%22lastName%22%3A%22Fila%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Modrak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ondrej%22%2C%22lastName%22%3A%22Cinek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milan%22%2C%22lastName%22%3A%22Macek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pavel%22%2C%22lastName%22%3A%22Drevinek%22%7D%5D%2C%22abstractNote%22%3A%22%3Ch2%3EAbstract%3C%5C%2Fh2%3E%3Cp%3ESuperior%20efficacy%20of%20elexacaftor%5C%2Ftezacaftor%5C%2Fivacaftor%20%28ELX%5C%2FTEZ%5C%2FIVA%29%20over%20tezacaftor%5C%2Fivacaftor%20%28TEZ%5C%2FIVA%29%20in%20people%20with%20cystic%20fibrosis%20%28CF%29%20and%20Phe508del%5C%2FPhe508del%20genotype%20was%20shown%20in%20clinical%20trials.%20We%20utilized%20intestinal%20organoid%20approach%20to%20compare%20%3Ci%3Ein%20vitro%3C%5C%2Fi%3E%20responses%20to%20these%202%20CFTR%20modulator%20drug%20combinations%20and%20to%20check%20potential%20inter-individual%20variability%20in%20therapeutic%20response%20to%20the%20triple%20combination.%20Organoids%20from%2017%20subjects%20with%20Phe508del%5C%2FPhe508del%20were%20screened%20with%20forskolin%20induced%20swelling%20assay.%20Significantly%20larger%20swelling%2C%20when%20exposed%20to%20ELX%5C%2FTEZ%5C%2FIVA%20as%20compared%20to%20TEZ%5C%2FIVA%2C%20was%20observed%20in%2016%20of%20them.%20However%2C%201%20sample%20showed%20no%20additional%20effect%20of%20ELX.%20The%20finding%20of%20unique%20CFTR%20variants%20in%20this%20sample%20indicates%20that%20genetic%20traits%20other%20than%20CF-causing%20CFTR%20mutation%20are%20worth%20exploring%20as%20they%20may%20have%20an%20impact%20on%20the%20definitive%20modulator%20drug%20response.%3C%5C%2Fp%3E%22%2C%22date%22%3A%222021%5C%2F08%5C%2F02%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jcf.2021.07.006%22%2C%22ISSN%22%3A%221569-1993%2C%201873-5010%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.cysticfibrosisjournal.com%5C%2Farticle%5C%2FS1569-1993%2821%2901304-7%5C%2Fabstract%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-05T16%3A27%3A17Z%22%7D%7D%5D%7D
Furstova, E., Dousova, T., Beranek, J., Libik, M., Fila, L., Modrak, M., Cinek, O., Macek, M., & Drevinek, P. (2021). Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis. Journal of Cystic Fibrosis, 0(0). https://doi.org/10.1016/j.jcf.2021.07.006 Cite
